{"DataElement":{"publicId":"7346812","version":"1","preferredName":"Ancillary Study HPV Typing Method Type","preferredDefinition":"The method used in a secondary study to perform human papillomavirus (HPV) genotyping.","longName":"7332294v1.0:7332237v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7332294","version":"1","preferredName":"Ancillary Study HPV Typing Method","preferredDefinition":"A study that is secondary to another study._The method used to perform human papillomavirus (HPV) genotyping.","longName":"7052721v1.0:7332292v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7052721","version":"1","preferredName":"Ancillary Study","preferredDefinition":"A study that is secondary to another study.","longName":"C16041","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ancillary Study","conceptCode":"C16041","definition":"A study that is secondary to another study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"973C983C-51FC-1152-E053-F662850AE6FF","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7332292","version":"1","preferredName":"HPV Typing Method","preferredDefinition":"The method used to perform human papillomavirus (HPV) genotyping.","longName":"C157255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HPV Typing Method","conceptCode":"C157255","definition":"The method used to perform human papillomavirus (HPV) genotyping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8261814-2FE1-4DD8-E053-4EBD850A1950","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8261814-2FF2-4DD8-E053-4EBD850A1950","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"KNABLEJ","dateModified":"2020-07-28","changeDescription":"7/28/20 jk Released per SME (NGM) review and approval email. 6/15/20 jk created for CPTAC CESC Baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7332237","version":"1","preferredName":"HPV Typing Method Type","preferredDefinition":"The method used to perform human papillomavirus (HPV) genotyping._Something distinguishable as an identifiable class based on common qualities.","longName":"7332237v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other HPV Typing Method","ValueMeaning":{"publicId":"7332239","version":"1","preferredName":"Other HPV Typing Method","longName":"7332239","preferredDefinition":"An indication that the method used to perform human papillomavirus (HPV) genotyping was identified in the study but is not present in the form.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other HPV Typing Method","conceptCode":"C159820","definition":"An indication that the method used to perform human papillomavirus (HPV) genotyping was identified in the study but is not present in the form.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8267CF0-C95B-4920-E053-4EBD850ACCD9","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8267CF0-C974-4920-E053-4EBD850ACCD9","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"Roche","valueDescription":"Roche HPV Lab Test","ValueMeaning":{"publicId":"7332241","version":"1","preferredName":"Roche HPV Lab Test","longName":"7332241","preferredDefinition":"A human papilloma virus test developed by Roche laboratories.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Roche HPV Lab Test","conceptCode":"C157414","definition":"A human papilloma virus test developed by Roche laboratories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8267CF0-C981-4920-E053-4EBD850ACCD9","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8267CF0-C99A-4920-E053-4EBD850ACCD9","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"Qiagen","valueDescription":"Qiagen HPV Lab Test","ValueMeaning":{"publicId":"7332243","version":"1","preferredName":"Qiagen HPV Lab Test","longName":"7332243","preferredDefinition":"A human papilloma virus test developed by Qiagen laboratories.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Qiagen HPV Lab Test","conceptCode":"C157415","definition":"A human papilloma virus test developed by Qiagen laboratories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8267CF0-C9A7-4920-E053-4EBD850ACCD9","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8267CF0-C9C0-4920-E053-4EBD850ACCD9","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"PCR","valueDescription":"Polymerase Chain Reaction","ValueMeaning":{"publicId":"3234683","version":"1","preferredName":"Polymerase Chain Reaction","longName":"3234683","preferredDefinition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-1572-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":"7-20-20 TMT updated concept with NCIt definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8267CF0-C9CA-4920-E053-4EBD850ACCD9","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7332236","version":"1","preferredName":"HPV Typing Method Type","preferredDefinition":"The method used to perform human papillomavirus (HPV) genotyping.:Something distinguishable as an identifiable class based on common qualities.","longName":"C157255:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HPV Typing Method","conceptCode":"C157255","definition":"The method used to perform human papillomavirus (HPV) genotyping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8267CF0-C930-4920-E053-4EBD850ACCD9","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8267CF0-C941-4920-E053-4EBD850ACCD9","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-15","modifiedBy":"KNABLEJ","dateModified":"2020-07-28","changeDescription":"7/28/20 jk Released per SME (NGM) review and approval email.  6/15/20 jk created for CPTAC CESC Baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6570063","version":"1","longName":"Cervix","context":"OCCPR"},{"publicId":"6779609","version":"1","longName":"CESC Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Method of HPV Typing","type":"Preferred Question Text","description":"Method of HPV Typing","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A962FCD0-3253-0B8F-E053-4EBD850A0BD5","latestVersionIndicator":"Yes","beginDate":"2020-07-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-07-01","modifiedBy":"KNABLEJ","dateModified":"2020-07-28","changeDescription":"7/28/20 jk Released per SME (NGM) review and approval email. 7/1/20 jk created for CPTAC CESC Baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}